Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable nicotinate-nucleotide adenylyltransferase NadD (deamido-NAD(+) pyrophosphorylase) (deamido-NAD(+) diphosphorylase) (nic | 0.0339 | 0.3812 | 1 |
Schistosoma mansoni | microtubule-associated protein tau | 0.082 | 1 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0053 | 0.0134 | 1 |
Echinococcus multilocularis | dna polymerase eta | 0.0053 | 0.0134 | 0.0134 |
Onchocerca volvulus | 0.0043 | 0 | 0.5 | |
Toxoplasma gondii | ABC1 family protein | 0.0043 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0098 | 0.0716 | 0.0716 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0053 | 0.0134 | 1 |
Schistosoma mansoni | apoptosis regulator bax | 0.0098 | 0.0716 | 0.0716 |
Loa Loa (eye worm) | apoptosis regulator protein | 0.0098 | 0.0716 | 1 |
Trichomonas vaginalis | esterase, putative | 0.0043 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0273 | 0.2966 | 0.7781 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0053 | 0.0134 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0098 | 0.0716 | 0.0716 |
Schistosoma mansoni | bcl-2 homologous antagonist/killer (bak) | 0.0098 | 0.0716 | 0.0716 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0 | 0.5 |
Echinococcus multilocularis | Bcl 2 ous antagonist:killer | 0.0098 | 0.0716 | 0.0716 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.0134 | 0.1873 |
Brugia malayi | Apoptosis regulator proteins, Bcl-2 family protein | 0.0098 | 0.0716 | 1 |
Mycobacterium ulcerans | bifunctional nicotinate-nucleotide adenylyltransferase NadD/hypothetical protein | 0.0339 | 0.3812 | 1 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0 | 0.5 |
Onchocerca volvulus | 0.0043 | 0 | 0.5 | |
Echinococcus multilocularis | EGFP:Bcl2 fusion protein | 0.0098 | 0.0716 | 0.0716 |
Mycobacterium leprae | PROBABLE NICOTINATE-NUCLEOTIDE ADENYLYLTRANSFERASE NADD (DEAMIDO-NAD(+) PYROPHOSPHORYLASE) (DEAMIDO-NAD(+) DIPHOSPHORYLASE) (NIC | 0.0339 | 0.3812 | 1 |
Plasmodium falciparum | nicotinamide/nicotinic acid mononucleotide adenylyltransferase | 0.0339 | 0.3812 | 0.5 |
Echinococcus granulosus | EGFP:Bcl2 fusion protein | 0.0098 | 0.0716 | 0.0716 |
Echinococcus granulosus | Bcl 2 ous antagonist:killer | 0.0098 | 0.0716 | 0.0716 |
Echinococcus granulosus | dna polymerase eta | 0.0053 | 0.0134 | 0.0134 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.082 | 1 | 1 |
Plasmodium vivax | nicotinate-nucleotide adenylyltransferase, putative | 0.0339 | 0.3812 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0098 | 0.0716 | 1 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0043 | 0 | 0.5 |
Treponema pallidum | hypothetical protein | 0.0339 | 0.3812 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0098 | 0.0716 | 0.0716 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0053 | 0.0134 | 0.1873 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0043 | 0 | 0.5 |
Schistosoma mansoni | DNA polymerase eta | 0.0053 | 0.0134 | 0.0134 |
Onchocerca volvulus | 0.0043 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.